Clinical practice guideline on diagnosis and treatment of hyponatraemia
Clinical practice guideline on diagnosis and treatment of hyponatraemia
复制标题
DOI：
10.1007/s00134-014-3210-2
复制
发表时间：
2014-03-01
影响因子：
38.9
通讯作者：
Nagler, Evi
中科院分区：
文献类型：
--
作者：
Spasovski, Goce;Vanholder, Raymond;Nagler, Evi
低钠血症定义为血清钠浓度< 135 mmol/L，是临床实践中遇到的最常见的体液和电解质平衡紊乱。低钠血症存在于15- 20%的急诊入院患者中，并且发生在高达20%的危重患者中。症状可能从轻微到严重，甚至危及生命。尽管如此，患者的管理仍然存在问题。在此背景下，欧洲重症监护医学会、欧洲内分泌学会和欧洲肾脏协会-欧洲透析和移植协会（由欧洲肾脏最佳实践代表）已制定了一项关于低钠血症诊断方法和治疗的临床实践指南，作为三个代表对低钠血症具有天然兴趣的专家的协会的联合企业。
Hyponatraemia, defined as a serum sodium concentration < 135 mmol/L, is the most common disorder of body fluid and electrolyte balance encountered in clinical practice. Hyponatraemia is present in 15-20 % of emergency admissions to hospital and occurs in up to 20 % of critically ill patients. Symptomatology may vary from subtle to severe or even life threatening. Despite this, the management of patients remains problematic. Against this background, the European Society of Intensive Care Medicine, the European Society of Endocrinology and the European Renal Association-European Dialysis and Transplant Association, represented by European Renal Best Practice have developed a Clinical Practice Guideline on the diagnostic approach and treatment of hyponatraemia as a joint venture of three societies representing specialists with a natural interest in hyponatraemia.